|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.62 HKD | +6.55% |
|
+9.38% | +25.76% |
| 07-16 | Genscript Associate Reports $657 Million in Carvykti Sales Under License Agreement | MT |
| 06-15 | Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma | MT |
Chart calendar Genscript Biotech Corporation
Upcoming events on Genscript Biotech Corporation
No events available
Past events on Genscript Biotech Corporation
| 05/06/2026 | Annual General Meeting | 02:30 |
| 16/03/2026 | Earnings presentation | 00:30 |
| 15/03/2026 | Board of Directors Meeting | |
| 15/03/2026 | Earnings presentation | 23:15 |
| 15/03/2026 | Earnings release - Annual 2025 | |
| 12/11/2025 | Analyst/Investor Day | |
| 18/08/2025 | Earnings presentation | 01:30 |
| 18/08/2025 | Earnings presentation | 00:15 |
| 16/08/2025 | Earnings release - Q2 2025 | |
| 16/08/2025 | Board of Directors Meeting |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 840 840 -0.1% | 594 1 166 -49.02% | 960 951 0.91% | 819 | 938 | 1 058 |
|
EBITDA Million USD | Released Forecast Spread | -337 -388 13.04% | 77,4 -174 144.47% | 328 350 -6.21% | 126 | 203 | 264 |
|
EBIT Million USD | Released Forecast Spread | -411 -427 3.73% | 15,8 -238 106.65% | 254 292 -12.97% | 68,4 | 89,6 | 112 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -351 -450 22.06% | -171 -344 50.42% | -471 52,8 -990.66% | 75,3 | 248 | 408 |
|
Net income Million USD | Released Forecast Spread | -95,5 -219 56.37% | 2 962 -198 1594.33% | -533 8,99 -6026.98% | 74,8 | 219 | 364 |
|
EPS USD | Released Forecast Spread | -0,05 -0,10 56.21% | 1,36 -0,09 1555.16% | -0,25 0,01 -4660.3% | 0,04 | 0,08 | 0,14 |
| Announcement Date | 10/03/24 | 12/03/25 | 15/03/26 | - |
Quarterly results
| Fiscal Period | December | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 | 2026 S1 | 2026 S2 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 561 548 2.49% | 33,1 647 -94.88% | 519 560 -7.42% | 441 441 -0.09% | 382 | 415 |
|
EBITDA Million USD | Released Forecast Spread | 114 117 -2.45% | 43,5 | 35,9 | |||
|
EBIT Million USD | Released Forecast Spread | -147 -126 -16.73% | 163 -134 221.59% | 179 255 -30% | 75,2 91,4 -17.66% | 17,6 | 9,93 |
|
EPS USD | Released Forecast Spread | -0,08 -0,01 -727% | 1,44 -0,01 14524% | -0,02 0,08 -127% | -0,23 -0,03 -680% | -0,01 | -0,01 |
| Announcement Date | 09/08/24 | 12/03/25 | 11/09/25 | 15/03/26 | - | - |
| 23/07/2026 |  | Earnings presentation | 14:00 |
| 23/07/2026 | | Earnings presentation | 13:00 |
| 23/07/2026 | | Earnings release - Q2 2026 | |
| 23/07/2026 | | Earnings release - Q2 2026 | 07:00 |
| 24/07/2026 | | Earnings release - Q1 2027 | |
| 24/07/2026 | | Board of Directors Meeting | |
| 25/07/2026 | | Earnings presentation | 05:30 |
| 28/07/2026 | | Earnings presentation | 14:00 |
| 28/07/2026 | | Earnings release - Q2 2026 | |
| 28/07/2026 | | Earnings presentation | 13:00 |
Past sector events for Genscript Biotech Corporation
| Today | | Earnings release - Q2 2026 | 05:30 |
| Today | | Earnings presentation | 13:00 |
| Today | | Earnings release - Q2 2026 | |
| 21/07/2026 | | Information meeting | 21:30 |
| 20/07/2026 | | Board of Directors Meeting | 12:00 |
| 20/07/2026 | | Extraordinary General Meeting | 07:30 |
| 17/07/2026 | | Présentation aux Actionnaires / Analystes | |
| 16/07/2026 | | Significant Split/Dividend | 05:00 |
| 16/07/2026 | | Ex-dividend date - 0.2 CNY | 05:00 |
| 16/07/2026 | | Extraordinary General Meeting | 03:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 1548 Stock
- Calendar Genscript Biotech Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition